LeadIQ logo
Learn more at LeadIQ.com

Insights

Leadership Expansion Kaleido Biosciences has recently made strategic leadership appointments, including the hiring of a new chief medical officer and the promotion of a senior vice president. This indicates a potential sales opportunity to engage with the expanded leadership team to explore new collaborations or partnerships.

Blockchain Partnership By partnering with Polygon, Kaleido Biosciences has ventured into the blockchain space, showing an openness to innovative technologies. This partnership presents a sales opportunity to offer complementary services or solutions that can enhance Kaleido's blockchain initiatives.

Biotech Acquisition Canva's acquisition of Kaleido Biosciences showcases industry recognition and potential synergies. Business development professionals can leverage this acquisition as a conversation starter to explore how Canva's resources and capabilities can further support Kaleido's goals and potentially create sales avenues.

Funding Milestone With a recent funding of $60 million, Kaleido Biosciences demonstrates financial strength and growth potential. Sales development representatives can capitalize on this milestone to present value-added solutions that align with Kaleido's expansion plans and contribute to their continued success.

Market Collaboration Through partnerships with renowned companies like Janssen Biotech, Kaleido Biosciences shows a commitment to collaborative research. This represents a sales opportunity for proposing joint initiatives or tailored solutions that cater to the evolving needs of Kaleido's market collaborations.

Similar companies to Kaleido Biosciences

Kaleido Biosciences Tech Stack

Kaleido Biosciences uses 8 technology products and services including SiteCatalyst, WordPress, Font Awesome, and more. Explore Kaleido Biosciences's tech stack below.

  • SiteCatalyst
    Analytics
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • jQuery
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security

Media & News

Kaleido Biosciences's Email Address Formats

Kaleido Biosciences uses at least 1 format(s):
Kaleido Biosciences Email FormatsExamplePercentage
First.Last@kaleido.comJohn.Doe@kaleido.com
73%
FLast@kaleido.comJDoe@kaleido.com
24%
Last@kaleido.comDoe@kaleido.com
2%
Last.First@kaleido.comDoe.John@kaleido.com
1%

Frequently Asked Questions

Where is Kaleido Biosciences's headquarters located?

Minus sign iconPlus sign icon
Kaleido Biosciences's main headquarters is located at 65 Hayden Ave Lexington, Massachusetts 02421 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Kaleido Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Kaleido Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kaleido Biosciences's stock symbol?

Minus sign iconPlus sign icon
Kaleido Biosciences is a publicly traded company; the company's stock symbol is KLDO.

What is Kaleido Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Kaleido Biosciences's official website is kaleido.com and has social profiles on LinkedIn.

How much revenue does Kaleido Biosciences generate?

Minus sign iconPlus sign icon
As of April 2024, Kaleido Biosciences's annual revenue reached $15M.

What is Kaleido Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Kaleido Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kaleido Biosciences have currently?

Minus sign iconPlus sign icon
As of April 2024, Kaleido Biosciences has approximately 51 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: R. M.Vice President Research And Development: C. M.Head Of New Product Planning: M. C.. Explore Kaleido Biosciences's employee directory with LeadIQ.

What industry does Kaleido Biosciences belong to?

Minus sign iconPlus sign icon
Kaleido Biosciences operates in the Biotechnology Research industry.

What technology does Kaleido Biosciences use?

Minus sign iconPlus sign icon
Kaleido Biosciences's tech stack includes SiteCatalystWordPressFont AwesomeTwitter Emoji (Twemoji)jQueryAmazon Web ServicesYoast SEOreCAPTCHA.

What is Kaleido Biosciences's email format?

Minus sign iconPlus sign icon
Kaleido Biosciences's email format typically follows the pattern of . Find more Kaleido Biosciences email formats with LeadIQ.

How much funding has Kaleido Biosciences raised to date?

Minus sign iconPlus sign icon
As of April 2024, Kaleido Biosciences has raised $60M in funding. The last funding round occurred on Feb 04, 2021 for $60M.

When was Kaleido Biosciences founded?

Minus sign iconPlus sign icon
Kaleido Biosciences was founded in 2015.
Kaleido Biosciences

Kaleido Biosciences

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are unyielding in our pursuit of life-changing therapies and our grit and compassion lead us to fight for a better future for patients and their families. 

We believe there is tremendous potential in the area of targeting the immune system through the gut microbiome. By working with the microbiome rather than replacing it, Kaleido is in a unique position to unlock an untapped area of science with unprecedented new treatments.

Section iconCompany Overview

Headquarters
65 Hayden Ave Lexington, Massachusetts 02421 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
KLDO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $60M

    Kaleido Biosciences has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Feb 04, 2021 in the amount of $60M.

  • $10M$50M

    Kaleido Biosciences's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $60M

    Kaleido Biosciences has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Feb 04, 2021 in the amount of $60M.

  • $10M$50M

    Kaleido Biosciences's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.